Amgen, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Contact
KS
Kathy Sherman
601 13th Street, NW, Suite 1100 North
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
601 13th Street, NW, Suite 1100 North
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
For
Notification Date4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
2019 Wisconsin Act 12
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
2019 Wisconsin Act 12
For
Notification Date4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars
Substitution of interchangeable biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/14/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/14/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $894.24 |
2019 July - December $0.00 |
2020 January - June $0.00 |
2020 July - December $0.00 |
Total $894.24 |
| Total Hours Communicating | 2019 January - June 1.00 |
2019 July - December 0.00 |
2020 January - June 0.00 |
2020 July - December 0.00 |
Total 1.00 |
| Total Hours Other | 2019 January - June 11.00 |
2019 July - December 0.00 |
2020 January - June 0.00 |
2020 July - December 0.00 |
Total 11.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 45% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 42% |
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 45% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 42% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication